Polymers for Drug-Device Combination Products

January 28, 2019

A wide variety of polymer types are available to the DDCP developer,
and many are available on the market that meet the necessary
regulatory requirements. Careful consideration should be given to
the choice of vendor to ensure that quality and consistency are
met. The available polymers span a wide range of physical properties
and are amenable to fabrication into devices using a variety of
processes. API can be readily incorporated into these polymers using
melt-mixing or solution processing. If product developers use
contract services for development or manufacturing, it is advisable to
select partners with a breadth of experience and a solid track record.

Spotlight

Quest Nutra Pharma Group

Quest Nutra Pharma is a manufacturer of nutraceuticals, pharmaceuticals, food supplements, botanical extracts and flavours, with factories and entities in the United Kingdom and the United Arab Emirates. The group has its own brands of nutraceuticals and pharmaceuticals, offers contract manufacturing services to other businesses, and also supplies the pharmaceutical, agricultural and food industries with flavours and botanical extracts. The operating entities within the group consist of Quest Vitamins Ltd, Quest Ingredients Ltd (formerly Flavex International Ltd) and Quest Middle East FZE. The factories within the group are certified with pharmaceutical-grade GMP by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and by other regulators around the world. The factories also have certifications for BRC Grade A, ISO 9001, FEMAS and SEDEX.

OTHER WHITEPAPERS
news image

How IPD Can Deliver for Life Sciences

whitePaper | January 1, 2020

Life sciences is facing a number of disruptors: novel cell and gene therapies that will revolutionize manufacturing, drug delivery and pricing models; a battle for the best and brightest talent; political and public pressure on the price of medication as well as the implications of the fourth industrial revolution. These factors combine to make investment decisions more challenging. With life sciences firms placing an increasing focus on the most efficient use of capital and shorter delivery times, project delivery providers are striving to come up with leaner and more innovative strategies and solutions to meet these needs. Integrated Project Delivery (IPD) is one such strategy.

Read More
news image

How Cellular is Enabling the Digital Supply Chain

whitePaper | January 12, 2020

Supply chains grow more and more complex every day. In response, manufacturers and shippers have been eagerly exploring digital tools that provide actionable insight into the location and condition of in-transit goods. Although there are many technology options when it comes to building a digital supply chain, one type of solution stands out as the most reliable and cost-effective: cellular.

Read More
news image

Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence

whitePaper | November 25, 2019

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

Defragmenting Data for the Future of Pharma R&D

whitePaper | November 7, 2019

This in-depth paper will show you how to become data agile – tackling both technological issues and solutions, and the cultural and strategic framework needed around this to ensure success.

Read More
news image

Research and Development in the Pharmaceutical Industry

whitePaper | April 1, 2021

Every year, the U.S. pharmaceutical industry develops a variety of new drugs that provide valuable medical benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and the federal government. Policymakers have considered policies that would lower drug prices and reduce federal drug expenditures. Such policies would probably reduce the industry’s incentive to develop new drugs.

Read More

Spotlight

Quest Nutra Pharma Group

Quest Nutra Pharma is a manufacturer of nutraceuticals, pharmaceuticals, food supplements, botanical extracts and flavours, with factories and entities in the United Kingdom and the United Arab Emirates. The group has its own brands of nutraceuticals and pharmaceuticals, offers contract manufacturing services to other businesses, and also supplies the pharmaceutical, agricultural and food industries with flavours and botanical extracts. The operating entities within the group consist of Quest Vitamins Ltd, Quest Ingredients Ltd (formerly Flavex International Ltd) and Quest Middle East FZE. The factories within the group are certified with pharmaceutical-grade GMP by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and by other regulators around the world. The factories also have certifications for BRC Grade A, ISO 9001, FEMAS and SEDEX.

Events